- Understanding Immunotherapy. Cancer.Net. Retrieved from: http://www.cancer.net/navigating-cancer-care/how-cancer-treated/immunotherapy-and-vaccines/understanding-immunotherapy. Accessed: 5/31/17.
- Immunotherapy. National Cancer Institute. Retrieved from: https://www.cancer.gov/about-cancer/treatment/types/immunotherapy. Accessed: 5/31/17.
- Pembrolizumab May Help Combat Mesothelioma. Oncology Nurse Advisor. Retrieved from: http://www.oncologynurseadvisor.com/lung-cancer/checkpoint-inhibitor-shows-antitumor-activity-in-mesothelioma/article/648001/. Accessed: 5/31/17.
- SELLAS™ Life Sciences Receives FDA Fast Track Designation of Galinpepimut-S for the Treatment of Malignant Pleural Mesothelioma. PR Newswire. Retrieved from: http://www.prnewswire.com/news-releases/sellas-life-sciences-receives-fda-fast-track-designation-of-galinpepimut-s-for-the-treatment-of-malignant-pleural-mesothelioma-300329701.html. Accessed: 5/31/17.
- Aduro Biotech Announces Clinical Collaboration with Merck to Evaluate the Combination of Aduro’s CRS-207 with Merck’s KEYTRUDA® (Pembrolizumab) for the Treatment of Mesothelioma. Aduro Biotech. Retrieved from: http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2273583. Accessed: 5/31/17.
Sources & Author